Skip to main content

Genome Institute of Singapore Buys Three SOLiD Systems

NEW YORK (GenomeWeb News) – Applied Biosystems said today that the Genome Institute of Singapore has acquired three SOLiD DNA sequencing systems for use in studying the genetic underpinnings of cancer and other diseases.
 
GIS already had one SOLiD system on site, according to ABI. Researchers at the institute are studying how structural variants, such as copy number variations, single-base duplications, inversions, translocations, insertions, and deletions, contribute to the development of cancer.
 
"We evaluated several technologies for this kind of research, and concluded that the SOLiD System fits very well with our paired end di-tag technology and will provide us with a platform that enables rapid, accurate and cost-effective study of a variety of types of genetic variants present in cancer genomes," Yijun Ruan, associate director for genomic technologies at GIS, said in a statement.
 
Financial terms of the purchase were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.